Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; Avdoralimab (IPH5401), a monoclonal antibody blocking C5a binding to C5aR1 that is in Phase II clinicals trials for the treatment of COVID-19, bullous pemphigoid, chronic spontaneous urticaria, and other inflammatory diseases; IPH5201, a blocking antibody that is in Phase 1 clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; and IPH6101, a NKp46-based NK cell engager for the generation and evaluation of up to two bispecific NK cell engagers. Its products in preclinical trials are IPH43, an anti-MICA/B antibody drug conjugate; Anti-Siglec-9, an antibody program; IPH65, a tetraspecific proprietary antibody; IPH25, a checkpoint inhibitor; and IPH62 and IPH64 programs. Innate Pharma S.A. has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. The company was incorporated in 1999 and is headquartered in Marseille, France.

Filer	Shares	Latest Filing Date	Previously owned	Change	Share-Type	Market Value
Morgan Stanley	56.11K	2021-05-17	5.13K	50.98K	Shares	242K
Millennium Management Llc	49.73K	2021-05-17	54.70K	-4.96K	Shares	214K
Exchange Traded Concepts, Llc	42.43K	2023-07-20	0	42.43K	Shares	133.23K
Optiver Holding B.V.	30.28K	2021-05-20	0	30.28K	Shares	131K
Citadel Advisors Llc	25.25K	2021-05-21	0	25.25K	Shares	109K
Lpl Financial Llc	12K	2021-05-14	0	12K	Shares	52K
Advisor Group Holdings, Inc.	2K	2021-05-13	0	2K	Shares	9K
Steward Partners Investment...	650	2021-05-17	1.10K	-450	Shares	2.80K
Wellington Management Group...	0	2021-05-17	1.33M	-1.33M	Shares	0
Concourse Financial Group S...	0	2021-05-13	0	0	Shares	0
Deutsche Bank Ag\	0	2020-08-13	100	-100	Shares	0
Ecor1 Capital, Llc	0	2020-08-14	4.47M	-4.47M	Shares	0
Rubric Capital Management Lp	0	2021-02-16	250K	-250K	Shares	0
Adage Capital Partners Gp, ...	0	2020-11-16	500K	-500K	Shares	0

NASDAQ:IPHA

Innate Pharma S.A.

Last Close

2.10

26/07 15:35

Market Cap

163.52M

Beta: 0.32

Volume Today

31.78K

Avg: 17.77K

PE Ratio

−1.87

PFCF: −9.30

Institutional trades

Institutional Ownership

Current holdings institutionals